0
Skip to content

CFPB’s FCRA Proposals Will Harm Small Businesses, Lenders, Medical Providers, Patients and All Consumers

ACA International calls on the bureau to expand research before finalizing rule.

08/13/2024 2:15 P.M.

4 minute read

Washington, D.C. – August 13, 2024 – ACA International (“ACA”) has filed comprehensive comments (PDF) in response to the Consumer Financial Protection Bureau’s (“CFPB”) proposals for sweeping changes to the Fair Credit Reporting Act (“FCRA”), identifying ruinous flaws in the proposal that will lead to more litigation against consumers and increased cost of credit and medical costs for communities across the country.

ACA’s CEO Scott Purcell states that in the comments that, “ACA and its members empathize with concerns that health care in this country is too expensive, and that work should be done in this area by the appropriate regulators and lawmakers. But the CFPB’s proposed rule does not have jurisdiction over the U.S. health care system, and its attempt to rewrite a federal law related to credit reporting does not solve that core issue because it focuses on the final stages of a lengthy and complex process of delivering and paying for medical care.

The proposed rule violates the law by impermissibly attempting to rewrite federal statute, failing to meet Regulatory Flexibility Act requirements, and because it is arbitrary and capricious. Worse yet, the proposed rule itself will cause significant harm to consumers, medical providers and patients, businesses, creditors, and the financial markets generally.”

ACA asks the CFPB to withdraw its proposed rule because:

  • It has not sufficiently addressed the concerns raised by multiple stakeholders, including the U.S. Small Business Administration (“SBA”) Office of Advocacy, during the Small Business Review Panel process.
  • It does not have sufficient data or research to support the very basis of the proposed rule that medical debt is not predictive and makes many other insufficient claims related to the usefulness of information about medical debt for lenders.
  • The CFPB does not have the legal authority to rewrite the FCRA or to make the changes outlined in its proposed rule to current law and regulations. The recent Loper Bright decision from the U.S. Supreme Court and the Major Questions Doctrine clearly prohibit the politically driven overreach that the CFPB and White House are attempting in the height of the election season.
  • Most concerning, however, are the many negative consequences that will occur if the CFPB moves forward with the proposed rule, as outlined in ACA’s comments letter and the enclosed research. Consumers around the country will face increased costs for both medical care and credit, less reliable health care options, more litigation, and a variety of other negative outcomes because of the CFPB’s uninformed policymaking.

In addition to ACA, stakeholders from the health care industry, representatives of financial institutions and other lenders, credit bureaus, the SBA Office of Advocacy, and a variety of other commenters have voiced opposition to the CFPB’s proposal. In its comments, the SBA Office of Advocacy stated that, “The CFPB prepared a certification and an initial regulatory flexibility analysis (IRFA) for the proposed rule. Advocacy asserts that neither the certification nor the IRFA complies with the requirements of the (Regulatory Flexibility Act.)”

SBA Office of Advocacy also raised several other significant concerns about the CFPB’s proposed rule.

ACA will build on the outreach in its comments by connecting with members of Congress on the proposed rule process and its role in addressing changes to the FCRA.

“We will continue to work to provide feedback so a more informed decision can be made when finalizing rules and legislation related to how patients access health care in America, how borrowers access credit and the related interest costs they incur,” Purcell said.

Accounts receivable management professionals and debt collectors work tirelessly to provide solutions and advocate on behalf of patients and medical providers to get insurance companies to pay the benefits that patients have paid for and are entitled to receive.

Debt collectors play a vital role in resolving medical debt and do their part every day to help make sure the insurance companies pay the right amount and assist consumers in resolving issues.

Enclosures:

Economic Analysis of the Consumer Financial Protection Bureau’s Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V) By Andrew Rodrigo Nigrinis, Ph.D. (PDF)

Small Business Administration Office of Advocacy Comments on the CFPB Proposed Rule on Prohibition on Creditors and Consumer Reporting Agencies Concerning Medical Information (Regulation V) (PDF)

###

ACA International (ACA), the association of credit and collection professionals, is the largest membership organization in the accounts receivable management industry. Founded in 1939, ACA brings together third-party collection agencies, law firms, asset buying companies, creditors and vendor affiliates representing industry professionals. ACA produces a wide variety of products, services and publications, including educational and compliance-related information; and articulates the value of the accounts receivable management industry to businesses, policymakers and consumers. www.acainternational.org.

If you have executive leadership updates or other member news to share with ACA, contact our communications department at comm@acainternational.org. View our publications page for more information and our news submission guidelines here.

Recently Posted

One moment please...

Share Profile

This site utilizes cookies as included in our Privacy Policy and User Agreement.